In:
Gynecology, Consilium Medicum, Vol. 21, No. 2 ( 2019-04-15), p. 23-27
Abstract:
The role of human papillomavirus (HPV) in the development of cervical cancer and other diseases of the anogenital area has been proven and well known. Despite this, the incidence of cervical cancer is growing every year. Specific methods of HPV treatment are not developed, and the only effective method of cervical cancer prevention is to prevent infection itself. A number of randomized clinical trials have demonstrated extremely high (up to 100%) effectiveness of HPV vaccines. Currently, the HPV vaccine is approved by WHO and included in the National Immunization Program of 86 countries, 17 counties use gender-neutral program. In the clinical practice of Australia, USA and countries of the European Union, in particular Italy, Germany and France, high efficiency of vaccination for 10 or more years is reported.
Type of Medium:
Online Resource
ISSN:
2079-5831
,
2079-5696
DOI:
10.26442/20795696.2019.2.190396
Language:
Unknown
Publisher:
Consilium Medicum
Publication Date:
2019
Permalink